Biopsys Medical Inc.: The Irvine developer and...

Biopsys Medical Inc.: The Irvine developer and manufacturer of products for the diagnosis and management of breast cancer posted third-quarter net income of $601,000, or 5 cents a share, contrasted with a net loss of $1 million, or 13 cents a share, for the comparable period of the preceding fiscal year. Sales for the quarter ended March 31 climbed to $4.3 million from $1 million.

Net income for the nine months totaled $607,000, or 6 cents a share, contrasted with a net loss of $2.5 million, or 33 cents a share, for the same period a year ago. Sales rose to $10 million from $1.8 million.